Researchers identify key player in genetic Parkinson’s Date 29 April 2020 A team of researchers at the University of York have shown a protein called Rab10 plays an important role in the loss of brain cells in LRRK2-associated Parkinson’s.
Cannabis extract may hold key to stop pain in Parkinson's Date 5 March 2020 Cannabis-based compounds could be the silver bullet to relieve pain for people with Parkinson’s according to the largest ever study into pain and the condition.
Potential treatment for dyskinesia in Parkinson’s Date 2 March 2020 Results from a one-year project, funded through the Parkinson’s Virtual Biotech, suggest that NLX-112 has potential as a future treatment for reducing dyskinesia and improving movement symptoms of Parkinson’s.
Initial results from CDNF clinical trial announced Date 26 February 2020 Herantis Pharma has published initial results from a phase 1/2 study of an experimental protective protein called CDNF which may hold potential to slow, stop or reverse Parkinson's.
GDNF: where are we 1 year on? Date 25 February 2020 GDNF clinical trial results in 2019 revealed signs that GDNF may make it possible to repair the cells damaged in people with Parkinson’s. We take a look at where we are 1 year later.
BT13 molecule offers hope for halting Parkinson’s Date 14 February 2020 A promising molecule, called BT13, has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do.
Gut bacteria could guard against Parkinson’s Date 14 January 2020 New research suggests that a bacteria which boosts digestive health can slow – and even reverse – the build-up of a protein associated with Parkinson’s.
Poll finds a quarter of people with Parkinson’s are wrongly diagnosed Date 10 January 2020 In our survey of more than 2,000 people, more than a quarter (26%) reported they were misdiagnosed with a different condition before receiving the correct Parkinson’s diagnosis.
8 remarkable things we achieved together in 2019, and recent years Date 17 December 2019 2019 was another exciting year of progress. Here are 8 of the highlights, and 8 ways you can still get involved.
Progress in gene therapy treatment for Parkinson's Date 5 December 2019 Researchers, funded by Parkinson's UK, have produced positive results in mice for a gene therapy treatment that directly targets the production of the alpha-synuclein protein.
